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Environmental enrichment induces axon regeneration and recovery after 
peripheral and spinal injuries via activity mediated CBP-dependent histone 
acetylation: a druggable pathway  
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One Sentence Summary: Environmental enrichment or pharmacological mediated CBP-
dependent histone acetylation increases regeneration potential of specific classes of neurons. 
 
Abstract: Injured axons fail to regenerate in the adult mammalian central nervous system 
(CNS), leading to permanent deficits in sensory and motor functions. We found that enhancing 
the activity of proprioceptive dorsal root ganglion (DRG) neurons through an enriched 
environment induces a long-lasting increase in their regenerative potential that is dependent on 
CREB Binding Protein (CBP)-mediated histone acetylation. Delivery of a small molecule 
activator of CBP acetyltransferase at clinically relevant times after spinal cord injury promoted 
regeneration and sprouting of sensory and motor axons, together with improvement in both 
sensory and motor functions. These findings open avenues for therapeutic developments in 









Following spinal cord injury (SCI), motor and sensory axons fail to regenerate, leading to 
permanent neurological impairments (1, 2). This absence of CNS regeneration after injury has 
been attributed to two main interconnected factors: the presence of growth inhibitory molecules 
in the CNS and the lack of an effective neuronal-intrinsic regenerative response (2-4). While 
axon regeneration fails in the CNS after injury, limited regeneration and partial functional 
recovery do occur in the injured peripheral nervous system (PNS) (5, 6). The best-established 
method for increasing the intrinsic regenerative capacity of sensory neurons in the dorsal root 
ganglion (DRG) consists of inducing a conditioning injury to the axons in the sciatic nerve 
prior to the CNS injury (7-9). While this has provided useful insights in the mechanisms 
underlying axon regeneration, a conditioning lesion only induces modest regeneration in the 
CNS and is not a clinically viable approach. 
 Sensory dorsal root ganglia (DRG) neurons convey afferent information from the 
periphery to the spinal cord in order to modulate motor outputs, and to supraspinal structures 
for the elaboration of sensorimotor integration and conscious perception. Amongst the DRG, 
proprioceptive neurons innervate muscle spindles and Golgi tendon organs. They transmit 
information about the length and tension of muscles, which plays a critical role during 
sensorimotor execution (10, 11). Moreover, proprioceptive afferent feedback plays an 
important role in directing motor recovery after SCI. Mice lacking functional proprioceptive 
afferents exhibit a defective rearrangement of descending pathways that prevents recovery after 
SCI (11). This observation indicates that proprioceptive neurons may deliver molecular cues 
for axonal regrowth and sprouting after injury. In turn, modulation of proprioceptive afferents 
with electrical stimulation (12, 13) and rehabilitative training (14) augments neuroplasticity 
and recovery in both animal models and humans after SCI (15). However, the underlying 
mechanisms remain poorly understood. 
Proprioceptors are ideally located for modulation by environmental stimuli. Here, we 
investigated the impact of environmental enrichment (EE) on proprioceptive DRG neurons, 
hypothesizing that this would prime them to initiate a regenerative response to a subsequent 
injury, similar to a conditioning injury. We show that augmenting the activity of proprioceptive 
DRG neurons using EE induces a lasting increase in their regenerative potential that is 
dependent on CREB Binding Protein (CBP)-mediated histone acetylation. In turn, 
pharmacologically increasing CBP acetyltransferase activity at clinically-relevant times and in 
clinically-relevant models of SCI promoted regeneration and sprouting of sensory axons and 
brainstem motor pathways that mediated improvements in both sensory and motor functions. 
These results show that neuronal activity leads to changes in chromatin environment that boost 
the regenerative capacity of neurons. Elucidating the mechanisms underlying activity-
dependent responses in neurons translated into the identification of a clinically-relevant 
pharmacotherapy for SCI that warrants evaluation in humans. 
 
Results  
Environmental enrichment induces a lasting increase in the regenerative potential of 
DRG neurons 
To test whether EE can enhance the regenerative potential of DRG neurons, mice were exposed 
to EE or standard housing (SH) for 1, 3, 6, 10 or 35 days. Neurite outgrowth of DRG neurons 
was significantly enhanced only after exposure to EE for 10 or 35 days on a growth permissive 
substrate (Fig. 1A and B). The extent of neurite outgrowth on myelin was similar to what is 
observed after a conditioning injury (Fig. S1), which represents the benchmark for stimulating 
DRG axon regeneration (9, 16). 
 EE-dependent neurite outgrowth was abolished when delivering the transcriptional 
inhibitor actinomycin-D in culture (Fig. S2), suggesting a dependence of this response on gene 
transcription. EE-dependent increase in neurite outgrowth was maintained during a 5-week 
period of SH after 10 days of EE (Fig. 1C, D and E), suggesting that EE may trigger long-
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lasting epigenetic reprogramming. Analyses of growth responses revealed that EE enhanced 
axon elongation rather than branching (Fig. S3), which may translate into axonal regeneration 
in vivo.  
Given the multifactorial nature of EE, we decided to discriminate between the relative 
role of running, which has previously been shown to enhance peripheral nerve regeneration 
(17) and the remaining environmental stimuli (larger cage, increased number of mice, novel 
objects, and increased nesting material) on DRG outgrowth. Mice were placed either in EE, in 
SH, in EE with an immobilised wheel or in SH with a running wheel for 10 days. Analysis of 
neurite outgrowth showed that although the running wheel in SH enhanced outgrowth 
compared to SH alone, the full complement of EE still induced a significantly higher degree of 
outgrowth (Fig. S4). This result indicated that the full EE is required for maximal enhancement 
of DRG outgrowth.  
 We next tested whether EE can also enhance regeneration of axons within the peripheral 
and the central nervous system. Prior exposure to EE enhanced sciatic nerve regeneration after 
complete transection and reanastomosis (Fig. 1F and G), along with increased muscle 
reinnervation after a sciatic nerve crush (Fig. S5). 
We then assessed whether pre-exposure to EE would enhance regeneration of sensory 
axons in the dorsal columns after a SCI and compared this response to the regeneration 
observed after a conditioning injury. Three groups of adult mice were exposed to EE or SH for 
10 days and then housed in SH, subsequently one SH group received a conditioning sciatic 
nerve axotomy (SNA) injury and the other SH and the EE groups underwent a sham injury. 
Next, all the mice received a thoracic (T12) dorsal hemisection. Five weeks later, the retrograde 
tracer Cholera Toxin subunit B (CTB) was injected into the sciatic nerves to evaluate the 
regeneration of ascending dorsal column axons (Figure 1H). The majority of labelled axons 
from SH Sham mice retracted from the injury site. In contrast, labelled axons from EE Sham 
mice could be observed within the lesion epicentre. Some regenerating axons even expanded 
beyond the lesion site, attaining distance up to 800 µm from the lesion border (Figure 1H and 
I). Some of these regenerating axons co-localized with vGlut1, suggesting the formation of 
putative synapses (Fig. S6). In the SH SNA group, we also found as expected axons traversing 
the lesion epicenter (Figure 1H and I). 
We conducted terminal electrophysiological experiments 6 weeks after injury to 
evaluate the functionality of these regenerating axons. The dorsal columns were stimulated 
below the injury at L5, and recorded both below and above the lesion, at L1 and T9, 
respectively (Figure 1J). In all the animals that underwent EE or SNA, compound action 
potentials could be recorded above the lesion site. However, the amplitude of these responses 
was significantly larger for the animals that had been housed in EE compared to SNA (black 
traces, Figure 1K and L), suggesting an increase in neuroplasticity across the lesion. There was 
no significant difference in the compound action potential recordings below the lesion for any 
of the groups (blue traces, Figure 1K).  
To assert that regenerating sensory axons were responsible for the increase in 
conduction through the lesion site, we specifically silenced these axons using designer 
receptors exclusively activated by designer drugs (DREADD), using methods that were 
described previously (18). We injected an AAV-flex-hM4Di into the sciatic nerve to express 
the Gi receptor into DRG neurons under Cre recombination. Three weeks after SCI, an AAV-
Cre was injected rostral to the site at of injury to express the Cre-dependent Gi-coupled 
DREADD only in those DRG neurons that had extended axons through and beyond the lesion. 
After 3 additional weeks, mice previously exposed to EE underwent electrophysiological 
assessment. In all tested mice, compound action potentials could be recorded beyond the lesion. 
Chemogenetic mediated silencing restricted to regenerated axons (Cre-dependent AAV-flex-
hM4Di) significantly reduced conduction across the lesion, establishing causality that was 
confirmed with a re-transection (Fig. 1K and L). 
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Proprioceptive afferent feedback is required for EE-mediated increase in DRG 
regenerative growth 
We next investigated whether a specific type of neurons were implicated in EE-dependent 
regenerative growth. We injected CTB into the distal sciatic nerve one day after performing a 
sciatic nerve crush injury. Consequently, only DRG neurons that regenerated an axon across 
the injury site and into the denervated side would be able to take up the CTB tracer (Figure 
2A). Two days after the CTB injection, we assessed the number of CTB-positive DRG neurons 
that co-stained for markers of the main DRG subpopulations (Figure 2B). Prior exposure to EE 
significantly increased the number of CTB positive DRG neurons (Figure 2C). The majority 
of DRG neurons, which regenerated axons through the sciatic nerve crush and were 
retrogradely labeled with CTB, expressed markers of proprioceptors (parvalbumin) rather than 
nociceptors (isolectin B4 or substance P) (Figure 2B and D), suggesting that EE specifically 
enhances the regeneration of proprioceptive axons. 
Next, we investigated whether the EE-dependent increase in regenerative potential of 
proprioceptive neurons relied on a muscle spindle proprioceptive mechanism. To this end, we 
used Egr3-/- mice that while retaining a similar number of parvalbumin (PV) DRG neurons 
compared to WT mice, this mutation abolishes muscle spindle proprioceptive feedback (11, 
19) (Figure 2E). We found that EE- but not conditioning injury-dependent DRG outgrowth was 
abolished in mice lacking intact muscle spindles (Egr3-/-) (Figure 2F and G). This observation 
demonstrates that EE-dependent regenerative priming is contingent on intact proprioceptive 
feedback.  
Finally, to further confirm the cell type specificity of the EE mechanism, we assessed 
neurite outgrowth of DRG neurons from mice that expressed tdTomato under the control of the 
PV promoter. Exposure to EE significantly increased the outgrowth of tdTomato positive 
(PVON) but not tdTomato negative (PVOFF) DRG neurons (Figure 2H and I). 
Taken together, these experiments demonstrate that prior exposure to EE specifically 
primes proprioceptive DRG neurons for enhanced axon regeneration. 
 
Environmental enrichment induces signaling pathways involved in neuronal activity, 
calcium mobilization and the regenerative program of large-diameter DRG neurons  
EE and exercise have been shown to increase neurotrophin expression and modify cytokines 
influencing neuroplasticity (17, 20-22). Surprisingly we found no changes in neurotrophin or 
cytokines levels in the DRG or in the blood (Fig. S7), suggesting that alternative mechanisms 
may be responsible for EE-dependent DRG regenerative growth.  
To uncover EE-dependent molecular mechanisms, we performed RNA sequencing 
(RNAseq) from whole DRG or laser-captured large-diameter DRG neurons (LDN) and 
conducted proteomic analysis from sciatic nerve axoplasm after EE or SH. Unsupervised gene 
expression clustering showed dramatic changes in gene expression of LDN after EE vs SH, but 
not in the whole DRG, which contains a multitude of different neuronal and glial cell types 
(Figure 3A, Fig. S8A, Files S1 and S2). These results confirmed that EE specifically modulates 
gene expression in proprioceptors and potentially mechanoreceptors. EE preferentially 
increased rather than repressed gene expression in LDN (Fig. S8B). Similarly, proteomic 
analysis showed a larger number of up-regulated proteins after EE vs SH (71 vs 49, Fig. S8C 
and File S3). Importantly, 37 out of 71 significantly up-regulated proteins were also up-
regulated at the RNA level, suggesting that gene transcription drove more than half of the 
observed protein changes (File S4). Functional classification of EE-dependent gene expression 
changes in LDNs revealed that EE strongly modulated functionally interconnected molecular 
pathways involving ion channels, neuronal activity, calcium signaling, energy metabolism and 
neuronal projection (Figure 3B, Fig. S8D and E, Files S5, S6, S7). Combined analysis of the 
RNAseq and proteomic datasets for protein-protein interactions identified multiple interactions 
between proteins involved in neuronal activity, calcium signaling and cytoskeletal 
rearrangements, supporting a role for EE-mediated activity in axon projection and elongation. 
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These results encouraged us to investigate the role of neuronal activity and calcium 
release in the EE-mediated increase in DRG regenerative potential. We employed an AAV-
mediated chemogenetics approach to inhibit or enhance neuronal activity of DRG neurons 
using DREADD technology. When activated by the pharmacologically inert ligand clozapine-
N-oxide (CNO), Gi-coupled (hM4Di) DREADD receptors inhibit adenylyl cyclase, which 
silences neuronal activity (23). Instead, activation of Gq-coupled (hM3Dq) DREADD 
receptors enhance neuronal activity by eliciting IP3-mediated calcium release from intracellular 
stores (23). This increase in intracellular calcium levels activates calcium-dependent signalling 
cascades, which would thus mimic the effects of EE on DRG neurons identified with gene and 
proteomic analysis. 
We injected AAV vectors into the sciatic nerve to express hM4Di, hM3Dq or GFP in 
DRG neurons. mCitrine/GFP expression confirmed an efficient transduction (Fig. S9). Four 
weeks after injection, mice expressing hM4Di, hM3Dq or GFP were placed in EE or SH. CNO 
was added in the drinking water to activate the receptors. Ten days later, we performed a sciatic 
nerve crush, and assessed the extent of regeneration three days post-injury (Figure 3C and D).  
Gq activation enhanced axon regeneration in SH mice and Gi-dependent inactivation 
of DRG neurons significantly attenuated axon regeneration of mice exposed to EE, 
demonstrating the importance of neuronal activity for EE-mediated regeneration (Figure 3C 
and D). Expression of Gi in SH mice or Gq in EE mice did not further impair or promote axon 
regeneration (Figure 3C and D). Similar results were obtained when assessing neurite 
outgrowth of DRGs cultured after in vivo DREADD transduction and EE exposure (Fig. S10). 
Gq expression in DRGs from SH mice significantly increased neurite outgrowth to a similar 
extent to what was observed in the DRGs of mice exposed to EE, while the expression of Gi in 
DRG neurons significantly reduced EE-dependent outgrowth (Fig. S10). 
 RNAseq and proteomics data suggests that EE may enhance calcium signalling in 
proprioceptive DRG neurons. To visualize this induction of activity-dependent signaling 
pathways in proprioceptive neurons in response to EE, we directly measured intracellular 
calcium levels in these cells, as an indicator of release from intracellular stores. Transgenic 
mice that expressed the genetically encoded calcium indicator GCaMP under the PV promoter 
were exposed to EE or SH. Whole sciatic DRGs were extracted in order to measure the 
fluorescent signals of proprioceptive neurons ex vivo when applying increasing levels of 
potassium chloride. As anticipated, we found that a prior exposure to EE significantly increased 
the levels of calcium in DRG neurons at all the potassium chloride concentrations tested 
compared to calcium levels measured in the DRGs of SH mice (Figure 3E and F, time-lapse 
videos S1 and S2). These observations show that EE increases calcium signalling in 
proprioceptive neurons, which is likely due to the increased solicitation of muscle spindles and 
force sensors within the enriched environment. 
 These results provide evidence that EE increases neuronal activity and calcium 
signalling in proprioceptive DRG neurons and plays an important role in the activity-dependent 
increase in regenerative potential. 
 
CBP mediated histone acetylation is required for EE-dependent increase in regeneration 
potential 
We reasoned that EE-dependent modulation of neuronal activity might induce epigenetic 
modifications enabling active transcription and a lasting increase in regenerative potential. 
Indeed, we found that EE enhanced H3K27ac and H4K8ac but not H3K9ac, H3K4me2 or 
H3K4me3 in parvalbumin-positive DRG neurons (Figure 4A, B and E, Fig. S11). H4K8ac and 
H3K27ac are both well-established markers of transcriptional activation, which correlated with 
our RNAseq data where we observed activation of gene expression in the large-diameter 
sensory neurons after EE (Fig. S8B). These two histones can be acetylated by CREB-binding 
protein (CBP) (24, 25), a lysine acetyltransferase that contains two calcium-sensitive 
transactivation domains (26) and involved in activity-dependent neuroplasticity (27-29). 
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Acetylation of CBP increases its acetyltransferase activity and facilitates transcription complex 
formation and acetylation of H4K8 and H3K27, leading to persistent changes in transcriptional 
activity (30, 31). EE significantly increased pCREB (Figure 4C, D and F) and active acetylated-
CBP (acCBP) expression in parvalbumin-positive DRG neurons (Figure 4G and H). Levels of 
H4K8ac but not pCREB or acCBP remained elevated in PVON DRG neurons 5 weeks after 
exposure to EE (Fig. S12). The levels of histone acetylation are likely maintained because they 
do not rely solely upon the histone deacetylase/acetyltransferase equilibrium but on the overall 
epigenetic configuration of the locus. While this is important for histones, it is unlikely for 
proteins, such as CBP, whose acetylation status directly depends on the activity of signal 
transduction pathways. Furthermore, the levels of H4K8ac and acCBP in DRG neurons were 
enhanced or inhibited by hM3Dq or hM4Di, respectively (Fig. S13), linking calcium-
dependent neuronal activity to histone acetylation.  
To further elucidate the role of CBP in the EE-mediated increase in the regenerative 
potential of DRG neurons, we used CaMKIIa-creERT2/CBPf/f transgenic mice with tamoxifen 
inducible CBP deletion in CaMKIIa positive cells (29). This population of neurons includes 
both large and medium diameter DRG neurons (32) (Figure S14). Four weeks after tamoxifen 
treatment, mice were placed in EE or SH for five weeks prior to the extraction of the sciatic 
DRG neurons. Neurite outgrowth was then assessed in culture. Importantly, the conditional 
deletion of CBP in CaMKIIa-positive DRG neurons (29) abolished the EE-dependent increase 
in neurite outgrowth (Figure 4I and J). This data suggests that CBP specifically contributes to 
mediating the increase in regenerative potential of DRG neurons after EE exposure. We also 
found that CBP deletion completely abolished the EE-mediated increase in H4K8ac (Figure 
4K), ruling out a significant role for other histone acetyltransferases. 
 
Pharmacological activation of CBP/p300 promotes sensory axon regeneration and 
recovery after a dorsal hemisection SCI in mice 
 The central role of CBP suggested that the pharmacological activation of CBP might 
mimic the EE-dependent increase in regenerative growth of DRG neurons. To test this 
hypothesis, we delivered a small-molecule activator of CBP/p300 (TTK21) after SCI. A recent 
study has shown that TTK21 is non-toxic, and when conjugated to glucose derived carbon 
nanospheres (CSP), TTK21 successfully crosses the blood brain barrier, effectively enhances 
histone acetylation in the hippocampus, and promotes improvements in learning and memory 
capacities (33).  
We first confirmed that the addition of CSP-TTK21 to DRG cultures was capable of 
increasing neurite outgrowth compared to control CSP. Indeed, CSP-TTK21, a 
pharmacological activator of CBP/p300 (33), triggered a significant increase in neurite 
outgrowth and H4K8ac in cultured neurons (Figure 5A and B). We next tested whether CSP-
TTK21 could promote axonal regeneration in vivo following a mid-thoracic dorsal hemisection 
(Figure 5C). Injured mice received a weekly i.p. injection of 20 mg/kg CSP-TTK21 or control 
CSP, beginning 4 hours after injury. To assess regeneration of sensory axons in the dorsal 
columns, we injected the sciatic nerves with CTB tracer and examined the spinal cord six weeks 
after SCI (Figure 5D). Treatment with CSP-TTK21 promoted sensory axon regeneration up to 
1000 µm rostral to the lesion (Figure 5E and F). We conducted behavioural assessments for 
five weeks after SCI to evaluate recovery of sensorimotor function. We selected tasks 
contingent on accurate proprioceptive information, which included the Gridwalk and adhesive 
tape test. We observed a decrease in the number of hindlimb slips in the gridwalk test (Figure 
5G) and a superior recovery in the time it took to sense and then remove a piece of adhesive 
tape placed on the hindpaws after treatment with CSP-TTK21 (Figure 5H, Fig. S15). Many of 
the regenerating axons from the CSP-TTK21 treated mice co-localized with vGlut1, suggesting 
the formation of putative synapses (Figure 5I and J). We then assessed the functionality of 
these regenerating axons with terminal electrophysiological experiments. We found a 
significant increase in the amplitude of compound action potentials recorded above the SCI in 
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treated mice compared to the control group, demonstrating that the CBP activator increased 
neural conduction across the lesion site (Figure 5K and L). In addition to promoting axon 
regeneration across the lesion site, we investigated whether CSP-TTK21 also increased 
sprouting of axons below the level of injury. CSP-TTK21 enhanced the number of vGlut1-
positive boutons apposed to motoneurons (putative synapses) in the ventral horn of the lumber 
enlargement (Figure 5M and N), suggesting spinal circuit reorganization and sprouting of 
group-Ia proprioceptive afferents below the injury. This reorganization of proprioceptive 
afferents has previously been associated with functional recovery (11, 14). We also observed a 
significant increase in the intensity of vGlut1 staining in lamina V of the spinal cord after CSP-
TTK21 treatment (Fig. S16). Importantly, CSP-TTK21 treatment significantly increased 
H4K8ac within DRG neurons (Fig. S17), but did not affect the scar area or GFAP intensity 
(Fig. S18). 
 
Pharmacological CBP/p300 activation enhances sprouting of both descending motor and 
ascending sensory axons leading to functional recovery after contusion SCI in rats 
To further substantiate the efficacy of CSP-TTK21 in vivo, we evaluated whether CSP-TTK21 
could promote anatomical and functional neuroplasticity of motor systems after a more 
clinically relevant SCI. Adult rats underwent a mid-thoracic spinal cord contusion (220 kdyn). 
CSP-TTK21 or CSP was administered i.p. 6 hours after SCI, which is a clinically-relevant time 
point after injury, and repeated weekly thereafter.  
To quantify locomotor performance, we applied a principal component (PC) analysis 
to various parameters calculated from kinematic recordings of quadrupedal walking along a 
flat corridor. PC1 captured the extent of the recovery, showing that CSP-TTK21 significantly 
improved locomotor performance compared to CSP-treated rats. Parameters that correlated 
with improved recovery included reduced paw dragging, increased step height and more 
frequent plantar steps with weight bearing (Figure 6A-D, Video S3). The number of footfalls 
occurring during locomotion across a horizontal ladder also decreased significantly (Fig. S19). 
This functional recovery was associated with increased sprouting of descending reticulospinal 
and serotoninergic axons within the lumbar spinal cord (Figure 6E-J). Accordingly, CSP-
TTK21 enhanced H4K8ac in the reticular formation and raphe nucleus (Fig. S20). CSP-TTK21 
also augmented the density of vGlut1-positive boutons from proprioceptors onto motoneurons 
located within lumbar segments below the injury (Figure 6K and L), which was associated with 
increased muscle responses evoked by stimulating proprioceptive afferents (H-reflex, Figure 
6M). However, CSP-TTK21 did not affect the lesion size or GFAP intensity (Fig. S21). 
 Together, these results show that activating CBP using a small-molecule promotes 
sprouting of descending pathways and proprioceptive afferents below injury associated with 
improved recovery of both sensory and motor functions after SCI. 
 
Discussion  
Our work demonstrates how increasing the neuronal activity of proprioceptive DRG neurons 
prior to an injury using EE or chemogenetics elicits CBP-mediated histone acetylation that is 
required for the enduring increase in axonal regeneration potential. Activating CBP using a 
small-molecule at clinically relevant time points and in clinically-relevant models of SCI 
mimicked the effect of increasing neuronal activity. CSP-TTK21 treatment promoted 
regeneration of ascending sensory axons and sprouting of both sensory and supraspinal motor 
axons below the lesion. The induced spinal circuit reorganization resulted in significant 
electrophysiological and behavioral recovery. Here, we discuss the role of activity on 
enhancing the regeneration potential of proprioceptive neurons as well as the molecular 
mechanisms underlying these effects before concluding on the implications for spinal cord 
repair and rehabilitation. 
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Activity-dependent mechanisms for priming the regeneration potential of proprioceptive 
neurons 
The complete lack of EE-mediated increase in neurite outgrowth observed in DRGs from mice 
with defective muscle spindle receptors demonstrates the importance of proprioceptive neurons 
and muscle spindle afferent feedback in triggering the activity-dependent increase in 
regeneration potential. This finding provides novel evidence and expands upon the recent 
demonstration that muscle spindle feedback is essential for inducing the correct anatomical 
reorganisation of projection neurons and functional recovery after spinal cord injury (11). 
Multiple pieces of evidence emphasised this remarkable cell type specificity. Furthermore, we 
found that EE drives the expression of genes underlying neuronal activity, calcium signalling 
and regenerative pathways in large-diameter DRG neurons. Indeed, this robust gene expression 
response was largely lost when RNAseq was performed from the whole DRG that contains 
multiple neuronal populations and glial cells, highlighting the specificity of EE-mediated gene-
expression in large-diameter DRG neurons, which are essentially composed of cells 
innervating proprioceptors. Finally, the impact of neuronal activity on axon regeneration could 
be reproduced experimentally. We showed that the manipulation of DRG neuronal activity 
using chemogenetics reproduced or abolished EE-mediated increase in axonal regeneration 
potential. Indeed, the increase in DRG neuronal activity alone triggered an increase in axon 
regeneration, further expanding upon what has been observed recently (34, 35).  
These data suggest that the effects of EE are essentially elicited by proprioceptive 
feedback signals, which leads to an enhanced activity of proprioceptive DRG neurons that 
promotes a lasting augmentation of their regenerative potential. 
 
Lasting increase in regeneration potential involves CBP-dependent histone acetylation 
Our results provided evidence that the lasting increase in regeneration potential resulted from 
a CBP-dependent increase in histone acetylation and a dramatic increase in gene expression, 
including pathways involved in neuronal activity, axonal projection and cytoskeleton 
remodelling. Specifically, neuronal activity elicited by EE activates CBP and increases the 
acetylation of H4K8. This enduring increase in histone acetylation likely mediates the long-
lasting enhancement in regenerative potential of these DRG neurons that extends for several 
weeks. The requirement of CBP was confirmed as deletion of CBP completely abrogated the 
EE-dependent increase in DRG neurite outgrowth and H4K8 acetylation. Furthermore, 
pharmacological activation of CBP after SCI promoted axonal regeneration and functional 
recovery. These data show that CBP is necessary for the EE-mediated increase in DRG neurite 
outgrowth and that its activation promotes functionally relevant axon regeneration and 
sprouting leading to recovery. These results expand upon recent studies by us and others 
showing that associated histone acetylation with a transcriptional-dependent enhancement of 
the regeneration program in neurons (36-41). We previously demonstrated that a conditioning 
injury activates p300/CBP associated factor (PCAF). Together with HAT p300, PCAF 
promotes acetylation of the promoters of known regeneration associated genes (RAGs), which 
facilitate their expression and thereby enhance axon regeneration after injury (36, 38, 39). The 
inhibition of HDACs promotes histone acetylation that can also promote axon regeneration 
(37, 40). Similarly, nuclear export of HDAC5 has been shown to be required for peripheral 
axon regeneration and for the induction of a number of RAGs (41). However, our present 
results show that EE-dependent histone acetylation does not involve PCAF since H3K9ac is 
not altered by EE and it does not require p300, since CBP deletion completely blocked EE-
dependent DRG regenerative growth. These observations suggest that a conditioning injury 
and EE operate via separate signalling mechanisms leading to distinct histone acetylation 
changes. However, a limitation of the present and previous studies is the lack of systematic 
screening for post-translational histone modifications that affect the histone code and gene 
transcription. The systematic measurement of histone acetylation and methylation could lead 
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to the identification of additional histone modifying enzymes that modulate EE-dependent or 
conditioning-dependent axonal regeneration in addition to CBP/p300 and PCAF. 
Collectively, these studies demonstrate the importance of the chromatin environment 
for the regenerative capacity of DRG neurons. Identifying and manipulating key histone 
modifiers that can orchestrate broad changes in gene transcription may lead to significant 
improvements in axon regeneration.  
 
Implications for spinal cord repair and rehabilitation 
The identification of the mechanisms underlying the activity-dependent increase in DRG 
regenerative growth allowed us to reproduce these effects pharmacologically. We show that 
the activation of CBP within a clinically relevant time frame after SCI using a non-toxic small 
molecule promotes regeneration of ascending and descending axons. CBP activation also 
triggered a robust sprouting of proprioceptive fibers below the injury, within the lumbar motor 
circuitry. These changes correlated with enhanced electrophysiological and behavioural 
functional recovery in sensory and motor tests. Although the specific contribution from each 
reorganized system remains unclear, we surmise that the reorganization of proprioceptive 
feedback circuits below the injury is more important to improve precision walking than the 
relatively short-distance regeneration of ascending fibers. While the specific mechanisms of 
recovery require to be studied further, these combined findings show that activity-dependent 
regenerative pathways triggered preceding a SCI can also be successfully targeted to enhance 
axon sprouting, regeneration and sensorimotor recovery after injury. 
 Rehabilitation strategies including exercises that increase afferent activity in the spinal 
cord are now well established to augment functional recovery in rodents after SCI, although 
their effect on axon regeneration in the CNS is not clear (42-44). Moreover, modulation of 
proprioceptive afferent circuits with electrical stimulation augments neuroplasticity and 
recovery after a SCI (13, 14, 45, 46). Thus, our results re-emphasized the critical role of 
proprioceptive neurons in steering the re-organisation of neural pathways that supports 
functional recovery after SCI.  
However, few studies have systematically investigated the impact of task-specific 
rehabilitation strategies prior to SCI on neuroplasticity and functional recovery. One study 
demonstrated that voluntary exercise prior to peripheral nerve injury enhances peripheral nerve 
regeneration (17). This observation is consistent with the robust axon regeneration resulting 
from an exposure to EE prior to a peripheral nerve injury. The study by Molteni et al reported 
an increase in neurotrophin mRNA in the DRG after exercise (17). Consequently, they used a 
pharmacological inhibitor of Trk tyrosine kinase to demonstrate that the exercise-mediated 
increase in DRG outgrowth was contingent on neurotrophin release. These findings differ from 
our data, since we did not observe any significant increase in neurotrophin mRNA or protein 
levels in DRGs after exposure to an EE. Along the same lines, a recent study has shown that 
exercise after SCI does not change neurotrophin expression in large-diameter DRG neurons 
(47). It is possible that the pharmacological inhibitor of Trk tyrosine kinase may have off-target 
effects altering multiple intracellular signalling pathways that lead to the reduction in DRG 
outgrowth. Voluntary exercise has been demonstrated to prevent the reduction of key signalling 
molecules that are involved in neuroplasticity including p-synapsin I, p-CREB and p-CaMK in 
the spinal cord and brain (48). Similarly, we found that EE triggers an increase in calcium 
related signalling molecules known to be important in gene regulation and inducing 
neuroplasticity. Involuntary exercise was recently shown to promote axon regeneration of 
propriospinal neurons but not sensory DRGs after a complete transection of the spinal cord and 
peripheral nerve graft (PNG) (49). This suggests that unlike the CBP activator used in the 
present study, increasing the activity of DRG neurons after a SCI using an exercise paradigm 
may be insufficient to increase the intrinsic regenerative state of the DRGs and promote sensory 
axon regeneration. Additionally, while we did not combine the CBP activator with 
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neurorehabilitation paradigms, this is worth investigating in the future since they might 
synergize for improved axonal plasticity and functional recovery. 
Finally, it is worth speculating upon the anecdotal evidence that individuals who had 
an “active lifestyle” recover to a greater degree after SCI than individuals who lived “less 
active” lifestyles. In addition to the global benefits associated with a healthy lifestyle, our 
combined observations prompt us to suggest that neurons are “primed” for axonal regeneration 
and sprouting, which contribute to this enhanced recovery. It will be useful to collect 
epidemiological data supporting or refuting this hypothesis.  
In summary, we have demonstrated an epigenetic-based mechanism underlying 
activity-dependent neuronal plasticity. The exploitation of this mechanism allowed us to utilize 
a novel pharmacotherapy that enhanced spinal cord repair and functional recovery after SCI, 
opening a realistic pathway for clinical evaluations. 
 
Materials and methods 
Fig. S1 Exposure to EE enhances neurite outgrowth on inhibitory myelin substrate to a similar 
extent as a conditioning SNA injury 
Fig. S2 Inhibiting transcription with actinomycin-D blocks the EE-mediated increase in DRG 
neurite outgrowth 
Fig. S3. Exposure to EE enhances axon elongation rather than branching 
Fig. S4. The full EE increases DRG neurite outgrowth compared to the running wheel alone 
Fig. S5. Exposure to EE enhances muscle re-innervation by proprioceptive DRG neurons 
Fig. S6. EE promotes axon regeneration and the formation of putative synapses 
Fig. S7. Neurotrophin and cytokine levels in the DRG and blood serum are not affected by EE 
Fig. S8. RNAseq and proteomic datasets demonstrate that EE strongly modulates pathways 
involved in neuronal activity, calcium signaling, gene expression and cytoskeletal changes 
Fig. S9. Efficient transduction and DREADD expression in parvalbumin positive DRGs 
Fig. S10. The EE-mediated increase in DRG neurite outgrowth is mediated by neuronal activity 
Fig. S11. H3K27ac is increased in parvalbumin positive DRGs after exposure to EE but the 
levels of H3K4me2, H3K9ac and H3K4me3 do not change compared to SH 
Fig. S12. Levels of H4K8ac but not acCBP or pCREB remain elevated in parvalbumin positive 
DRGs for 5 weeks after exposure to EE 
Fig. S13. Increasing neuronal activity augments the level of H4K8ac and acCBP in DRG 
neurons 
Fig. S14. The CaMKIIa promoter is active in DRG neurons and drives strong expression of 
tdTomato after tamoxifen treatment 
Fig. S15. CSP-TTK21 treatment significantly enhances the time to remove adhesive tape 
placed on the hindpaw 
Fig. S16. CSP-TTK21 treatment promotes sprouting of afferent fibres below the level of injury 
Fig. S17. CSP-TTK21 treatment enhances H4K8ac in the DRG 
Fig. S18. CSP-TTK21 treatment does not affect the glial scar after a thoracic dorsal spinal cord 
hemisection in mice 
Fig. S19. CSP-TTK21 significantly reduced the number of slips during locomotion along a 
horizontal ladder 
Fig. S20. CSP-TTK21 treatment enhances levels of H4K8ac in the raphe nucleus and reticular 
formation 
Fig. S21. CSP-TTK21 treatment does not affect the glial scar after a thoracic contusion spinal 
cord injury in rats 
Table S1. Table compiling the 78 parameters used for quantifying gait features. 
Video S1. EE mediated calcium mobilization in proprioceptive DRG neurons 
Video S2. SH mediated calcium mobilization in proprioceptive DRG neurons 
Video S3. Treatment with CSP-TTK21 enhances hindlimb function and over-ground 
locomotion 
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File S1. WholeDRG_EEvs StHousing DE 
File S2. LDN_EEvsStHousing DE 
File S3. DE Proteins EEvsStHousing 
File S4. LDN EEvsSHUpregulated 
File S5. LDN_GOandKEGG 
File S6. ClueGOResultclustering_LDN 
File S7. ClueGOResultclustering_LDN_selected for STRINGbis 
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Figure. 1. Environmental enrichment induces a lasting increase in the regenerative 
potential of sensory neurons. a, Cultured mouse sciatic DRGs after exposure to EE, stained 
for Beta-III-tubulin. Scale bar 100 µm. b, Quantification of neurite outgrowth (mean ± SEM, 
Unpaired Student’s t-tests ***P<0.001, n = 4/group). c, Diagram illustrating the experimental 
design, sciatic DRGs were cultured from mice that had been placed in EE for 10 days and then 
returned to SH for up to 5 weeks. d, Example images of sciatic DRGs from mice that had been 
in SH or EE for 10 days and then SH for 5 weeks. Scale bar 100 µm. e, Quantification of neurite 
outgrowth indicated that DRGs from mice that had been exposed to EE still had significantly 
increased neurite outgrowth compared to SH controls (mean ± SEM, unpaired Student’s t test 
*** P<0.001, n = 4/group).f, Sciatic nerves immunostained for SCG10 after transection and 
re-anastomosis, Scale bar 500 µm. g, Quantification of regenerating axons (mean ± SEM, Two-
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way ANOVA, Holm-Sidak post-hoc, ***P<0.001, **P<0.01, *P<0.05 n = 6/group). h, CTB-
traced (red) dorsal column axons after injury, DAPI (blue), lesion site (dashed line). Scale bar, 
200 µm. i, Quantification of CTB positive regenerating axons (mean ± SEM, Two-way 
repeated measures ANOVA, Tukey’s post-hoc **P<0.01, ***P<0.001, n = 10/group). j, 
Electrophysiological setup. k, Compound action potentials recorded below (blue) and above 
(black) injury. l, Quantification of compound action potentials above the lesion (mean ± SEM, 
One-way ANOVA, Fisher’s LSD post-hoc ***P<0.001, n = 6/group). 
 
Figure. 2. Proprioceptive afferent feedback is required for EE-mediated increase in DRG 
regenerative growth. a, Schematic of the experimental design, after EE and SH exposure mice 
underwent sciatic nerve crush injury and CTB injection distal to the crush site, axons that 
regenerate across the injury site take up CTB and retrogradely transport it to the soma. b, 
Representative images of co-localization between parvalbumin, substance P or isolectin B4 
(green) and CTB (red) in DRGs from EE mice that had undergone a sciatic nerve crush. Scale 
bar, 50 µm. c, Quantification of the number of CTB positive DRG neurons suggests EE 
significantly enhances axon regeneration compared to SH (mean ± SEM, unpaired Student’s t 
test, ** P<0.01, n = 3/group). d, Quantification of the percentage of CTB positive neurons that 
co-localized with parvalbumin, substance P or isolectin B4 demonstrates high levels of co-
localization between CTB and parvalbumin after exposure to EE. e, Schematic showing Egr3 
mutation resulting in degeneration of muscle spindles. f, Beta-III-tubulin stained sciatic DRGs 
from WT or Egr3-/- mice after exposure to SH or EE .Scale bar 100 µm. g, Quantification of 
neurite outgrowth. (mean ± SEM, One-way ANOVA, Tukey’s post-hoc, ***P<0.001, n = 
4/group). h, Example images of tdTomato (red) positive or tdTomato negative DRGs co-
stained with beta-III-tubulin (green) cultured from PV-cre x tdTomato mice that had been 
exposed to either SH or EE for 10 days. Scale bar 100 µm. i, Quantification of neurite 
outgrowth showed EE significantly increased outgrowth of PV-tdTomato+ DRGs compared to 
PV-tdTomato- DRGs (mean ± SEM, One-way ANOVA, Tukey’s post-hoc, ** P<0.01, *** 
P<0.001, n = 5/group). 
 
Figure. 3. EE induces signaling pathways involved in neuronal activity, calcium 
mobilization and the regenerative program of large-diameter DRG neurons. a, Heatmap 
of the differentially expressed (DE) genes in whole-DRG and LDN RNA-seq (P<0.05). Color 
scale represents arbitrary expression units (lowest, blue; highest, red). b, Pie chart of genes in 
each functional group identified by GO analysis of DE genes in LDN. Functional groups are 
color-coded. c, Sciatic nerves transduced with AAV5-GFP, AAV5-hM4Di-mCitrine or AAV5-
hM3Dq-mCitrine labeled with mCitrine/GFP after sciatic nerve crush. Arrow-head: lesion site. 
Scale bar, 500 µm. d, Quantification of axon regeneration (mean ± SEM, Two-way repeated 
measures ANOVA, Tukey’s posthoc, ***P<0.001, n = 6/group). e, Time-lapse images of 
intracellular calcium release from whole-mount PV-GCaMP DRGs before and after addition 
of 150 mM KCL. Scale bar, 50 µm. f, Quantification of F/Fo ratio after 50 mM, 100 mM and 
150 mM KCl (mean ± SEM, Two-way ANOVA, Sidak’s post-hoc **P<0.01, ***P<0.001, n = 
4/group). 
 
Figure. 4. CBP is required for EE-dependent increase in regeneration potential. a, DRGs 
stained for H4K8ac (green), parvalbumin (red) and DAPI (blue). Scale bar, 50 µm. b, 
Quantification of H4K8ac intensity (mean ± SEM, unpaired Student’s t test *** P<0.001, n = 
6/group). c, Examples images of DRGs from mice housed in SH or EE, which were double 
stained for pCREB (green) and parvalbumin (red). Scale bar, 50 µm. d, Quantification of the 
fluorescence intensity of pCREB in the nuclei of parvalbumin positive DRGs show as 
significant increase 10 days after EE compared to SH (mean ± SEM, unpaired Student’s t test 
*** P<0.001, n = 4/group). e, Immunoblotting analysis for H4K8ac from protein extracts from 
whole sciatic DRGs after 10 days exposure to SH or EE. Shown is a significant increase in the 
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expression of H4K8ac following exposure to EE (mean ± SEM, unpaired Student’s t test, ** 
P<0.01, n = 3/group). H4K8ac was normalised the levels of H4, while GAPDH was used as a 
loading control. f, Immunoblotting analysis for pCREB from protein extracts of whole sciatic 
DRGs revealed that exposure to EE significantly increased levels of pCREB compared to SH 
(mean ± SEM, unpaired Student’s t test ** P<0.01, n = 3/group).  pCREB was normalised to 
levels of CREB, while GAPDH was used as a loading control. g, DRGs stained for acCBP 
(green) and total CBP (red). Scale bar, 50 µm. h, Quantification of acCBP intensity (mean ± 
SEM, unpaired Student’s t test *** P<0.001, n = 11/group). i, Cultured DRG neurons from WT 
x CBPf/f or CaMKIIa-creERT2 x CBPf/f mice (Beta-III-tubulin, red and H4K8ac, green). Scale 
bar, 200 µm. j, Quantification of neurite outgrowth (mean ± SEM, One-way ANOVA, Tukey’s 
post-hoc *** P<0.001, n = 5/group). k, Quantification of H4K8ac intensity (mean ± SEM, One-
way ANOVA, Tukey’s post-hoc *** P<0.001, n = 5/group). 
 
Figure. 5. Pharmacological activation of CBP/p300 promotes sensory axon regeneration 
and recovery after a dorsal hemisection SCI in mice. a, Cultured DRG neurons treated with 
control (CSP) or CBP/p300 pharmacological activator (CSP-TTK21) (Beta-III-tubulin, red and 
H4K8ac, green). Scale bar, 50 µm. b, Quantification of neurite outgrowth (mean ± SEM, 
unpaired Student’s t test **P<0.01, n = 4/group) , H4K8ac intensity (mean ± SEM, unpaired 
Student’s t test **P<0.01, n = 4/group) and neurite branching (mean ± SEM, unpaired Student’s 
t test *P<0.05, n = 4/group) c, T9 dorsal column axotomy lesions ascending sensory axons in 
the dorsal columns. d, CTB (red) was injected into the sciatic nerve 5 weeks after SCI. e, CTB-
traced (red) dorsal column axons after SCI, GFAP (green), DAPI (blue), lesion site (dashed 
line). Scale bar, 200 µm. f, Quantification of CTB positive regenerating axons (mean ± SEM, 
Two-way repeated measures ANOVA, Holm’s Sidak post-hoc ***P<0.001, **P<0.01, 
*P<0.05, n = 8/group). g, Quantification of slips (mean ± SEM, Two-way repeated measures 
ANOVA, Fisher’s LSD post-hoc *P<0.05, n = 8/group). h, Quantification of the time it took 
to first contact an adhesive pad placed on the hindpaws (mean ± SEM, Two-way repeated 
measures ANOVA, Fisher’s LSD post-hoc ***P<0.001, **P<0.01, *P<0.05, n = 8/group). i, 
Representative image from a control CSP treated mouse showing very few CTB-positive 
regenerating axons rostral to the lesion and little co-localization with the pre-synaptic marker 
vGlut1. Lesion site is marked by the dashed line and asterisk. Scale bar, 100 µm, scale bar for 
insets 10 µm. j, Representative image from a CSP-TTK21 treated mouse showing co-
localization of regenerating CTB (red) positive axons rostral to the spinal cord injury site 
(marked by the dashed line and asteriks) with the pre-synaptic marker vGlut1 (green) to 
identify prospective nascent synapses (marked by arrows). Scale bar, 100 µm. Higher-
magnification images of insets show co-localization of CTB positive axons (red) and vGlut1 
(green). Scale bar, 10 µm. k, Compound action potentials recorded below (grey) and above 
(black) the lesion. l, Quantification of compound action potentials above the lesion (mean ± 
SEM, unpaired Student’s t test **P<0.01, n = 8/group). m, vGluT1 positive boutons (white) 
from Group-Ia afferents in proximity to hindlimb motoneurons (Red, CTB) below the injury 
(L1-4). Scale bar, 25 µm. n, Quantification of vGluT1 positive boutons opposed to 
motoneurons (mean ± SEM, unpaired Student’s t test **P<0.01, n = 8/group).  
 
Figure. 6. Pharmacological CBP/p300 activation enhances sprouting of both descending 
motor and ascending sensory axons leading to functional recovery after contusion SCI in 
rats. a, Image showing joints used for reconstruction of hindlimb movements b, Representative 
hindlimb kinematics after treatment with CSP or CSP-TTK21.  Black, orange and grey 
correspond to stance, drag and swing phases of gait, respectively. c, PC analysis of gait 
parameters averaged for each group at weeks 1, 4 and 8 and quantification of average scores 
on PC1, which quantify the locomotor performance of rats treated with CSP or CSP-TTK21 
(mean ± SEM, Two-way ANOVA, Fisher’s LSD post-hoc * P<0.05, n = 10/group). d, Bar 
plots of drag duration and step height show significant improvements after CSP-TTK21 
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treatment (mean ± SEM, unpaired Student’s t test * P<0.05, **P<0.01, n = 10/group). e, 
Schematics showing strategy for tracing vGi axons, T9 contusion and the L4 ventral horn 
analyzed for vGi and 5HT sprouting. f, CSP-TTK21 increased sprouting of descending vGi 
axons (Red) observed around motoneurons (ChAT, Cyan) in the lumbar ventral horn. Scale 
bar, 50 µm. g, Quantification of vGi intensity in the ventral horn (mean ± SEM, unpaired 
Student’s t test, ***P<0.001, n = 10/group). h, CSP-TTK21 increased sprouting of descending 
5HT axons (Magenta) was observed around motoneurons (ChAT, Cyan) in the lumbar ventral 
horn. Scale bar, 50 µm. i, Quantification of 5HT intensity in the ventral horn (mean ± SEM, 
unpaired Student’s t test, ***P<0.001, n = 10/group). j, Sagittal  sections  showing CSP-TTK21  
increased  sprouting  of  descending  vGi  (Red)  and  5HT  (Green)  axons  around  motoneurons  
(ChAT,  White)  below  in  the  injury  in  the  lumbar  ventral  horn.  Scale  bar,  50  μm. K, 
vGluT1 positive boutons (yellow) from Group-Ia afferents in proximity to motoneurons 
(ChAT, Cyan) below the injury (L1-4). Scale bar, 25 µm. l, Quantification of vGluT1 positive 
boutons opposed to motoneurons (mean ± SEM, unpaired Student’s t test ***P<0.001, n = 
10/group). m, The amplitude of the H-wave significantly increased after treatment with CSP-
TTK21 (mean ± SEM, One-way ANOVA, Tukey’s post-hoc * P<0.05, n = 10/group). 
 
 
Materials and Methods 
 
Study design 
We investigated the impact of environmental enrichment (EE) on proprioceptive DRG neurons, 
hypothesizing that EE would prime these neurons to initiate a regenerative response to a 
subsequent injury. Augmenting the activity of proprioceptive DRG neurons using EE induces 
and is required for an increase in neurite outgrowth and axon regeneration that is dependent on 
CREB Binding Protein (CBP)-mediated histone acetylation. In turn, pharmacologically 
increasing CBP acetyltransferase activity at clinically-relevant times and in clinically-relevant 
models of spinal cord injury promoted regeneration and sprouting of sensory and brainstem 
motor axons that mediated improvements in both sensory and motor function. All surgical and 
experimental procedures on rodents were carried out in accordance with the UK Animals 
(Scientific Procedures) Act 1986 and approved by the veterinarian and ethical committee of 
Imperial College and the canton of Vaud and Geneva. Animals were assigned randomly to 
experimental groups and surgeries were carried out in a random block design. All analysis was 
performed by the same experimenter who was blinded to the experimental groups. All 
behavioral testing and analysis was performed by an observer blinded to the experimental 
groups. N values represent the number of animals in the experiment and each experiment 
contained a minimum of 3 technical replicates. Behavioral assays were replicated two or three 
times per time-point, depending on the experiment.  
 
Animal models 
All procedures were carried out in accordance with the UK Animals (Scientific Procedures) 
Act 1986 and approved by the veterinarian and ethical committee of Imperial College and the 
canton of Vaud and Geneva. Male C57BL/6J mice (Charles River Laboratories, UK) ranging 
from 6 to 8 weeks of age were used for all experiments except those specifying transgenic 
mice. Female WT/lox-tdTomato, CaMKIIa-Cre-ERT2/lox-tdTomato, CaMKIIa-Cre-
ERT2/CBPf/f, WT/CBPf/f mice with a C57BL/6J genetic background have been previously 
described(29). For CBP ablation experiments, tamoxifen (T5648; Sigma) was administered to 
4 week old CaMKIIa-creERT2/CBPf/f mice using a gastric probe for 5 consecutive days (total 
consumption ~20 mg per animal); control animals were non-cre recombinase expressing CBPf/f 
mice (WT/CBPf/f) treated with tamoxifen. PV-cre x GCaMP and PV-cre x tdTomato mice on 
a C57BL/6J genetic background were provided by the Courtine laboratory. Egr3-/- mice 
containing the Egr3 mutant allele previously described(19) were maintained on a C57BL/6J 
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genetic background and provided by the Courtine lab. Adult female Lewis rats (180–220 g 
body weight, 14–30 weeks of age) were used for the CBP activator experiment. 
 
Animal housing 
Animals were kept on a 12 hr light:dark cycle with food and water provided ad libitum. 
Standard housing for mice consisted of 26x12x18 cm3 cages housing 4 mice with tissue paper 
for bedding, a tunnel and a wooden chewstick. The enriched environment housing consisted of 
36x18x25 cm3 cages housing 8 mice with tissue paper for bedding, a tunnel and a wooden 
chewstick. EE cages also received additional nesting material which included nestlets, rodent 
roll and sizzle pet (LBS biotech). EE cages continually contained a hanging plastic tunnel (LBS 
biotech) and a plastic igloo combined with a fast-track running wheel (LBS-biotech). In 
addition to this EE cages received a wooden object (cube, labyrinth, tunnel, corner 15) (LBS 
biotech) that was changed after 5 days to help maintain a novel environment. The EE cages 
also received 15 g fruity gems (LBS biotech) every 5 days to encourage exploratory and natural 
foraging behaviour. Rats were house in standard housing conditions with 3 rats per cage. 
 
DRG culture 
Glass coverslips were coated with 100 µg/ml poly-D-lysine (Invitrogen) in H2O for 2 hours at 
room temperature. The PDL was removed and washed 3 times with PBS (Invitrogen, UK), 
after which they were coated with 2 µg/ml of laminin (Millipore) for 2 hours at 37 oC. For the 
inhibitory myelin substrate, 8 µg/cm2 of extracted rat myelin was added to the laminin coated 
coverslip for 2 hrs at room temperature before removing the myelin and leaving to air dry for 
30 mins. L4-L6 DRGs were dissected and collected in Hank’s balanced salt solution (HBSS) 
(Invitrogen) on ice. DRGs then underwent enzymatic digestion (5 mg/ml Dispase II (Sigma), 
2.5 mg/ml Collagenase Type II (Worthington) in DMEM (Invitrogen) and incubated at 37 oC 
for 45 min with occasional mixing. DRGs were then transferred to media containing 10% heat-
inactivated fetal bovine serum (Invitrogen, UK), B27 (Invitrogen) in DMEM:F12 (Invitrogen) 
mix and were briefly triturated with a 1 ml pipette to manually dissociate the DRG. After which, 
the single cell suspension was spun down, re-suspended in media containing 1x B27 and 
Penicillin/Streptomycin in DMEM:F12 mix and plated at 4,000 cells per coverslip and 4,500 
per coverslip for the myelin substrate. The culture was maintained in a humidified incubator at 
5% CO2 and 37 oC for 12 or 24 hours before fixing with 4% PFA (Sigma) in PBS (Sigma). For 
thetranscriptional inhibition experiment 0.01 µg/µl or 1 µg/µl Actinomycin-D was added to the 
culture media at time of DRG plating. 
 
Immunocytochemistry 
Cultures were fixed with 4% PFA (Sigma) for 20 mins at room temperature and then washed 
with 1X PBS (Invitrogen). The cells were blocked with 10% normal donkey serum (Sigma) in 
PBS + 0.3% Triton-X for 1 hour at room temperature. Primary antibodies used were: Beta-III-
tubulin (1:1000, Promega G712A) and H4K8ac (1:1000, Abcam ab15823). Primary antibodies 
were diluted in 10% normal donkey serum (Sigma) in PBS + 0.3% Triton-X and left incubating 
with the cells for 4 hours at 4 oC. Primary antibodies were removed and the cells washed 3 
times in 1X PBS. This was followed by incubation with Alexa Fluor 568-conjugated Donkey 
anti-mouse and Alexa Fluor 488-conjugated Donkey anti-rabbit (1:1000, Invitrogen) in PBS + 
0.3% Triton-X for 2 hours at room temperature. To visualize the nucleus, the cells were stained 
with DAPI (1:5000, Molecular Probes) in PBS + 0.3% Triton-X. 
 
Sciatic nerve axotomy, crush and reanastomosis 
Mice were anesthetised with 3% isoflurane in 1 L/min oxygen and given a subcutaneous 
injection of 5 mg/kg Rimadyl and 0.1 mg/kg Buprenorphine for perioperative analgesia. A 
small incision was performed at the gluteal region and the muscles blunt dissected to expose 
the sciatic nerve. For SNA the sciatic nerve was completely transected using micro-scissors 
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(Fine Science Tools). For the crush injury the sciatic nerve was crushed using no.5 fine forceps 
(Fine Science Tools) keeping constant firm pressure for 10 seconds. For reanastomosis the 
nerve was completely transected as above and the two ends were re-anastomosed using two 2.0 
sutures. The skin was then closed with two suture clips. For sham surgeries the sciatic nerve 
was exposed but left uninjured. Regeneration was assessed 1 day after the crush and 3 days 
after the reanastomosis.  
 
Intramuscular injection 
Fourteen days post sciatic nerve crush sensory axons that had re-innervated the muscle were 
traced by injecting 5 µl of 1% CTB (List Biological Laboratories) diluted in saline into the 
tibialis anterior and medial gastrocnemius muscles using a 10 µl Hamilton syringe and 
Hamilton needle (NDL small RN ga34/15mm/pst45o) (Hamilton). 4 days post-tracing, mice 
were terminally anaesthetised and transcardially perfused with 20 ml PBS (pH 7.4) (Sigma) 
followed by 20 ml 4% paraformaldehyde in PBS (Sigma). 
 
Dorsal hemisection injury 
Surgeries were performed as previously reported (39). Briefly, mice were anesthetised with 3% 
isoflurane in 1 L/min oxygen and given a subcutaneous injection of 5 mg/kg Rimadyl and 0.1 
mg/kg Buprenorphine for perioperative analgesia. A laminectomy at vertebra T9 was 
performed to expose spinal level T12 and a dorsal hemisection until the central canal was then 
performed using micro-scissors (Fine Science Tools). For the sham surgery a laminectomy was 
performed but the dorsal hemisection was not. Any bleeding was stopped and the muscle and 
skin was sutured closed. 
 
Contusion injury Rats were anesthetised with 3% isoflurane in 1 L/min oxygen, a partial 
laminectomy was made at the T9 vertebra. Contusion injury was produced using a force-
controlled spinal cord impactor (IH-0400 Impactor, Precision Systems and Instrumentation). 
The applied force was set to 220 kdyn (1 dyn = 10 µN). The spinal cord displacement 
induced by the impact was measured for each animal. Analgesia (buprenorphine, 0.01–
0.05 mg/kg, s.c.) and antibiotics (Baytril 2.5%, 5–10 mg/kg, s.c.) were provided for 3 days 
after surgery 
 
Axonal tracing - Mice 
Six weeks post spinal cord injury the sensory axons in the dorsal columns were traced by 
injecting 3 µl of 1% CTB (List Biological Laboratories) diluted in saline into the sciatic nerve 
using a 10 µl Hamilton syringe and Hamilton needle (NDL small RN ga34/15mm/pst45o) 
(Hamilton). 4 days post-tracing, mice were terminally anaesthetised and transcardially perfused 
with 20 ml PBS (pH 7.4) (Sigma) followed by 20 ml 4% paraformaldehyde in PBS (Sigma). 
 To trace DRG neurons that regenerated an axon across a sciatic nerve crush, 2 µl of 1% 
CTB (List Biological Laboratories) diluted in saline was injected into the sciatic nerve 1 day 
after the crush injury using a 10 µl Hamilton syringe and Hamilton needle (NDL small RN 
ga34/15mm/pst45o) (Hamilton). 2 days post-tracing, mice were terminally anaesthetised and 
transcardially perfused with 20 ml PBS (pH 7.4) (Sigma) followed by 20 ml 4% 
paraformaldehyde in PBS (Sigma). 
 
Axonal tracing - Rat 
Nine weeks post contusion injury an AAV vector was injected (AAV8-CAG-DIO-tdTomato-
COMET, titre 1.03x1013 vg/ml, kindly provided by Prof. M. Tuszynski) into the ventral 
gigantocellular (vGi) for tract-tracing was performed in rats. Under isoflurane anesthesia, a 
craniotomy was performed over the brainstem medulla oblongata. Injection coordinates for 
rats were –11, –11.5, –12 mm caudal, ±0.8 mm mediolateral to bregma and 9.5 mm ventral 
from the surface of the cerebellum (six injections total, 250 nl per injection, injected with a 
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Hamilton injection system). The AAV vector was injected at 3 nl/s and the needle was held 
in place for 3 min before being slowly retracted. Five weeks after the AAV injections rats 
were terminally anaesthetised and transcardially perfused with 200 ml PBS (pH 7.4) (Sigma) 
followed by 200 ml 4% paraformaldehyde in PBS (Sigma). 
 
Histology and immunohistochemistry 
Tissue was post-fixed in 4% paraformaldehyde (PFA) (Sigma) and transferred to 30% sucrose 
(Sigma) overnight to cryoprotect, the tissue was then embeded in OCT compound (Tissue-Tek) 
and frozen at -80 oC . DRGs were sectioned at 10 µm thickness and mouse spinal cord at 15 
µm, rat spinal cord at 30 µm and rat brainstem at 40 µm using a cryostat (Leica). Tissue sections 
were blocked for 1 h with 10% normal donkey serum (Sigma), 0.3% Triton X-100 (Sigma) in 
PBS, and then incubated with, and H4K8ac (1:1000, ab15823), H3K27ac (1:500, ab4729), 
H3K9ac (1:500, Cell Signalling 9671), H3K4me3 (1:500, Abcam ab8580), H3K4me2 (1:500, 
Cell signalling 9726), Parvalbumin (1:1000, Abcam ab64555), Substance P (1:250 ab67006), 
IB4 (1:250, Invitrogen 121411), CBP (1:50, Abcam ab50702), acCBP (1:1000, Abcam 
ab61242), pCREB (1:100, Abcam ab32096), SCG-10 (1:500, Novus biologicals NBP1-49461), 
CTB (1:1000, List biological 703), vGlut1 (1:1000, Synaptic system 135302), 5-HT (1:6000, 
Sigma S5545), ChAT (1:200 Chemicon AB144P), GFAP (1:500, Millipore AB5804) 
antibodies O/N. This was followed by incubation with Alexa Fluor 568-conjugated donkey 
anti-mouse and Alexa Fluor 488-conjugated donkey anti-rabbit or Alexa Fluor 568-conjugated 
donkey anti-rabbit and Alexa Fluor 488-conjugated donkey anti-mouse (1:1000, Invitrogen), 
respectively. Slides were counterstained with DAPI to visualise nuclei (1:5000, Molecular 
Probes). Photomicrographs were taken with a Nikon Eclipse TE2000 microscope with a 
optiMOS scMOS camera using 10x or 20x magnification.  
 
Image analysis 
Image analysis was performed using ImageJ (Fiji) software. All analysis was performed by the 
same experimenter who was blinded to the experimental groups. 
 
Analysis of neurite outgrowth 
The mean neurite outgrowth per DRG neuron was manually measured using the NeuronJ 
plugin for ImageJ. We measured the mean neurite outgrowth of 75 neurons per mouse with at 
least 4 mice per group and 3 technical replicates per mouse. The EE-mediated increase in DRG 
outgrowth was also independently verified by our collaborators in Miami (Lemmon/Bixby lab), 
strengthening the reproducibility of this phenotype. 
 
Analysis of immunohistochemistry for epigenetic marks, pCREB, CBP and acCBP 
For quantitative analysis of pixel intensity, the nucleus or soma of DRG neurons were manually 
outlined in images from one series of stained tissue for each mouse. To minimise variability 
between images pixel intensity was normalize to an unstained area and the exposure time and 
microscope setting were fixed throughout the acquisition. 
 
 
Analysis of vGi and 5HT fibres in the ventral horn 
Intensity of 5HT immunohistochemistry or tdTomato fluorescent protein labelling of the vGi 
fibres was measured in the ventral horn of L1-4 spinal sections. Quantification was done using 
ImageJ, the background was subtracted and then the mean pixel intensity was measured from 
one series of tissue for each animal. 
 
Analysis of vGlut1 immunohistochemistry in proximity to motor neurons 
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vGlut1, a pre-synaptic marker labelling proprioceptive or cutaneous sensory afferent terminals 
was used to identify boutons in close proximity to motor neurons, which had been retrogradely 
traced with CTB. To determine the number of vGlut1 boutons in close proximity to motor 
neurons, consecutive confocal images (0.3 μm thick optical sections) were acquired as Z-stacks 
(total average thickness: 15 μm) using a 40x objective. The Average number of vGlut1 boutons 
opposed to motor neurons in the ventral horn of L1-3 spinal sections was calculated by 
analysing at least 20 motor neurons per animal. 
 
Analysis of GFAP intensity and area around the lesion site 
GFAP intensity and area was quantified from sagittal spinal cord sections from one series of 
tissue for each animal. Quantification was done using ImageJ, the background was subtracted 
and then the mean pixel intensity and area of immune-reactivity was measured. 
 
Analysis of CTB positive dorsal column axon regeneration in the spinal cord 
Regeneration of dorsal column axons were quantified from sagittal spinal cord sections from 
one series of tissue for each mouse. CTB intensity was quantified using ImageJ software at set 
distances rostral to injury centre then expressed as a percentage of the CTB intensity caudal to 
the injury site to control for variations in tracing efficacy. 
 The furthest rostral CTB positive axon was determined relative to the lesion centre and 
caudal axon retraction was defined as distance the lesioned axon bundle retracted relative to 
the lesion centre. 
 
Analysis of SCG10 and mCitrine axon regeneration after sciatic nerve injury 
The regeneration of peripheral axons in the sciatic nerve was quantified from one series of 
tissue from each mouse. SCG10 or mCitrine intensity was quantified using ImageJ software at 
set distances distal to injury site then expressed as a percentage of the pixel intensity proximal 
to the injury site to control for variations in staining or transduction efficiency. 
 
Behavioral analysis 
Mice were trained daily for 2 weeks pre-surgery before baseline measurements and then 
assessed on day 3 post-surgery and weekly thereafter. All behavioral testing and analysis was 
done by an observer blinded to the experimental groups. 
Gridwalk – Mice crossed a 1 m long horizontal grid 3 times. Videos of the runs were 
analysed at a later time-point and errors from both hind-limbs were counted. Error values 
represent the total number of slips made by both hind-limbs over the 3 runs. 
Horizontal ladder – Rats walked across a 1 m long horizontal ladder 3 times. Videos 
of the runs were analysed and errors from both hind-limbs were counted. Error values represent 
the total number of slips made by both hind-limbs over the 3 runs. 
Adhesive tape test – An 8 mm diameter adhesive pad was placed on each hind-paw. 
The mouse was then placed into plexi-glass box and the time until it first made contact with 
each of the adhesive pads was recorded, followed by the time until it removed the adhesive 
pads from each hind-paw. The maximum time allowed for each animal was 5 mins. Each 
animal was tested twice per time-point and values represent the average time from both 




All procedures used have been detailed previously (12, 14). Kinematic recordings were 
obtained from rats walking over-ground along a horizontal runway. Bilateral hindlimb 
kinematics were captured with a Vicon high-speed motion capture system (Vicon Motion 
Systems), using 12 infrared cameras (200 Hz). Reflective markers were attached bilaterally 
at the iliac crest, the greater trochanter (hip joint), the lateral condyle (knee joint), the lateral 
malleolus (ankle) and the distal end of the fifth metatarsophalangeal joint. The body was 
modeled as an interconnected chain of rigid segments, and joint angles were generated 
accordingly. For both the left and right legs, 10 step cycles were extracted randomly over 
several trials on the runway for each rat at each time point. 
 
Analysis of kinematic recordings 
A total of 78 parameters quantifying gait features were computed for each leg and each gait 
or stroke cycle according to methods described in detail previously(12, 14). All parameters 
are reported in Supplementary Table 1. To evaluate differences between experimental 
conditions and groups, as well as the most relevant parameters to explain these differences, 
we implemented a multistep statistical procedure based on principal component (PC) 
analysis. PC analyses were applied to data from all individual gait cycles for all rats together. 
Data were analysed using the correlation method, which adjusts the mean of the data to 0 
and the s.d. to 1. This method of normalization allows the comparison of variables with 
disparate values (large vs. small values) as well as different variances. Locomotor 
performance was quantified with the score along PC1, which segregated differences between 
groups. Factor loading of parameters on PC1, i.e. the correlations between each parameter 
and PC1 explaining recovery, are reported in Table S1. 
 
Electrophysiology 
Mice were anaesthetized with an IP injection of 50 mg/kg ketamine and 0.5 mg/kg 
medetomidine. Their thoracic and lumber back was shaved and disinfected with chlorhexidine. 
Mice were kept on a heating blanket throughout the procedure and anesthesia depth was 
monitored and the anaesthesia topped up if needed. Laminectomies were performed at 
vertebrae levels T13, T11 and T7 to expose spinal levels L5, L1 and T9. A concentric bipolar 
stimulating electrode (FHC CBBPC75) was placed over the dorsal columns at L5 for local 
surface stimulation (stimulation range: 100 µsec at 0.1 mA to 0.5 mA, 0.2 Hz). Field potentials 
were recorded at either L1 (below the injury) or T9 (above the injury) with a fine 
microneurography electrode (in-house custom made) inserted superficially into the spinal cord. 
Recordings were filtered between 300 and 6 kHz; amplified by 4 k. The animals were grounded 
with a 30 G needle through the skin. The traces had a typical positive-negative-positive 
waveform corresponding to the compound action potential in the dorsal column (50) with a 
conduction velocity of around 25 msec (51). To capture all components of the compound action 
potentials, we analysed the area under the curve by measuring the absolute integral of the 
curves (between 1 and 11 msec). 5 traces were averaged per mouse for analysis and 
representation at a stimulation intensity that distinctively excites dorsal column fibres 
controlled for by recording from below the lesion site. 
 
Hoffmann-Reflex Testing 
Electrophysiology was performed as previously reported (52). Briefly, rats were anaesthetized 
with 30 mg/kg ketamine and 0.1 mg/kg medetomidine and two 24-G needle electrodes were 
inserted across the lateral side of the ankle for nerve stimulation (via a constant current isolated 
pulse stimulator, stimulus width 100 μs). Two recording electrodes were inserted into the 
medial plantar foot to record electro myograms. The signal was amplified (1000-fold), filtered 
(10 Hz to 5 kHz), digitized via PowerLab, visualised and analysed with LabChart. The M-wave 
is evoked by excitation of motor axons. The H-wave is the monosynaptic reflex: Ia 
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proprioceptive afferents synaptically activate motor neurons in the spinal cord. The threshold 
was determined as the lowest stimulation intensity that elicited a H-wave response in at least 
75% of the recordings. First, the responses to increasing stimulus intensities were tested at 0.1 
Hz up to 2 x threshold. M-wave and H-wave amplitudes were normalized to the maximum M-
wave recorded at higher stimulation intensities. 
 
Laser capture micro-dissection 
Sciatic L4-L6 DRGs were extracted from 3 mice per condition. Using RNase-free conditions, 
DRGs were embedded with Tissue Freezing Medium (Triangle Biomedical Sciences, Inc) and 
frozen in dry ice-cold 2-methylbutane. 16 µm thick sections were cut on the cryostat and 
collected on Leica PEN-membrane slides (Leica). From each animal, 4-6 slides were obtained. 
Toluidine blue (Sigma) staining was used to identify the DRG neurons. Slides containing 
sections were dehydrated and stained with ethanol series, as follow: 3 times of 30 seconds in 
70% ethanol, 60 seconds in 0.5% Toluidine blue dissolved in 70% ethanol, 2 times for 30 
seconds each in 70% ethanol, 1 time for 30 seconds in 90% ethanol, 2 times for 30 seconds in 
100% ethanol. Once air-dried the slides underwent laser capture using a Leica LMD 6000 




Proteins from L4–L6 DRGs were extracted using RIPA buffer with protease and 
phosphatase inhibitor cocktails (Roche), lysed for 30 min on ice followed by 30 min 
centrifugation at 4 °C. Protein concentration was quantified using Pierce BCA Protein Assay 
Kit (ThermoScientific). Subsequently, 10–50 μg protein was loaded in SDS–polyacrylamide 
gel electrophoresis (PAGE) gels and transferred to polyvinylidene difluoride (PVDF) 
membranes for 2 h. Membranes were blocked with 5% BSA or milk for 1 h at room 
temperature and then incubated with H4K8ac (1:1000, ab15823), H4 (1:1000, Abcam 
ab10158), CREB (1:500, Abcam ab178322), pCREB (1:500, Abcam ab32096) or GAPDH 
(1:1000, cell signaling 14C10) antibodies at 4 °C overnight. Membranes were then incubated 
with HRP-linked secondary antibody (GE Healthcare) for 1 h at room temperature and 
developed with ECL substrate. 
 
RNA sequencing 
RNA sequencing was performed using RNA from whole DRG tissue and from large diameter 
laser microdissected DRG neurons in 3 biological replicates. For whole DRG RNAseq, sciatic 
L4-L6 DRGs were extracted from 2 mice per sample and stored in RNase later (Qiagen). DRG 
tissue was crushed with RNAse free micropestle and RNA was extracted using RNAeasy kit 
(Qiagen), according to manufacturer’s protocol. Residual DNA contamination was removed 
by on column DNase I treatment (Qiagen) for 15 min at room temperature. RNA concentrations 
and quality were measured using Agilent 2100 Bioanalyzer (Agilent). RNA with RIN factor 
above 7.5 was used for library preparation. Libraries were prepared at Ospedale San Raffaele 
(Milan) using the TruSeq mRNA Sample Preparation kit (Illumina) and sequenced using 
Illumina HiSeq 2500 100-cycle, pair end sequencing.  
For Laser captured DRG neurons, RNA was extracted using Arcturus PicoPure RNA 
isolation kit (Life Technologies), following manufacturers protocol. RNA concentrations and 
quality were measured using Agilent 2100 Bioanalyzer (Agilent). RNA with RIN factor 
between 6 and 7 were used for library preparation. Libraries were prepared using the RiboZero 
ScriptSeq V2 kit working from the low input protocol using 100 ng of RNA per sample.  
Libraries were sequenced using Illumina HiSeq 2500 generating 125 bp, paired end reads. 
Sequence reads were aligned to the mm10 mouse reference genome sequence using tophat 
version 2.0.12 running Bowtie2-2.2.3. Gene structure annotations corresponding to the 
Ensembl annotation of the mm10 genome sequence were used to build a transcriptome index 
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and provided to tophat during the alignment step. The aligned reads were sorted using 
samtools-0.1.19 and read counts per gene were obtained from mapped reads using HTSeq-
0.6.1. EdgeR version 3.8.6 (using limma-3.22.7) in R-3.1.1 was used to identify differentially 
expressed genes. Read-level quality checking was performed using fastqc-0.10.1 and the 
fastqc-aggregator (https://github.com/staciaw/fastqc_aggregator) and gene-level quality 
checking was performed using RSeQC-2.6.1. The gene expression in EE was compared to SH. 
Heatmap of RNAseq mRNA expression levels of the genes differentially expressed in any 
sample group (P<0.05) was generated using Euclidean unsupervised hierarchical clustering in 
Matlab R2014b using the custergram function.  
Gene ontology (GO) and KEGG (Kyoto Encyclopedia of Genes and Genomes) were 
performed on the differentially expressed genes with DAVID (Database for Annotation, 
Visualization, and Integrated Discovery (http://david.abcc.ncifcrf.gov/)) using a threshold of 
P<0.05. Functional GO clustering was performed using ClueGO in Cytoscape 
(http://www.cytoscape.org): (Bonferroni P<0.05) (GO tree interval min3, max8) (GO selection 
min 4, 1%) (K score 0.3).  Differentially expressed proteins and genes that resulted enriched in 
the GO functional clustering were uploaded into STRING to build a protein-protein interaction 
network. The network was visualized by Cytoscape, where each node represents a differentially 
regulated gene (RNA-seq) or protein (proteomic) and edges represent protein-protein 
interactions. 
 
Axoplasm extraction and proteomics 
Sciatic nerves were dissected and the axoplasm was obtained according to the previously 
published protocol (53). LC-MS was performed on axoplasmic samples by the Quantitative 
Biology Center (QBiC) in Tuebingen followed by proteomics analysis. Each axoplasmic 
extract processed for proteomics was derived by pooling 16 nerves dissected from 8 mice that 
were housed for 10 days in either SH or EE in biological triplicates and technical duplicates. 
The raw data was processed with MaxQuant version 1.5.0.25. The protein and peptides 
intensities were normalized using the "quantile normalization" procedure in R. The differential 
expression analysis of the proteins and peptide modifications was performed by the means of 
mixed linear models R (nlme) and ANOVA. The effect of treatment (SH vs EE) on protein 
expression was modelled as: intensity ~ treatment, with technical replicates nested within 
biological replicates as random factor. Correction for multiple hypothesis testing was done by 
R (qvalue) at FDR < 0.05. 
 
Ca imaging 
PV-cre x GCaMP mice were housed in EE or SH for 10 days. L4-L6 DRGs were extracted and 
immediately suspended in HBBS without Ca2+ (Thermofisher) with 10 mM Hepes 
(Thermofisher) at 37oC, 5% CO2. The DRGs were then placed into a video-microscopy 
chamber at 37oC and suspended in HBSS without Ca2+ (Thermofisher), to avoid any calcium 
influx from extracellular medium. Time-lapse recordings were taken with images acquired 
every 1 second for 5 minutes. Imaging was done on a Nikon Eclipse TE2000 microscope with 
a optiMOS scMOS camera using 20X magnification. After 30 seconds of baseline recording, 
increasing concentrations (50 mM, 100 mM and 150mM) of KCL (Sigma) were added to the 
DRG to elicit depolarisation and induce intracellular Ca2+ release. Quantification was done 
using the ImageJ plug-in Time series analyser, where the soma of all PV neurons were analysed 
per DRG, 6 DRG’s per mouse and 4 mice per condition. To determine the fold-change in 
GCaMP intensity after KCL addition, the GCaMP intensity ratio “F/Fo” was calculated by 
dividing the average fluorescence intensity after KCL addition “F” with the average intensity 




Sciatic L4-L6 DRGs (pool of 4 mice) and serum (pool of 2-4 mice) were collected in 3 
biological replicates.  100 µl of serum (corresponding to 1.5 mg of proteins) was run on a 
Mouse Cytokine Array Panel A (R&D System) and developed according to manufacturer’s 
protocol to quantify cytokine levels. The resulting spots on the membrane were quantified by 
densitometry and the signal intensity in the EE samples was referred to the SH control. 
 
Neurotrophin ELISA 
Levels of neurotrophins were analysed in homogenised L4-6 DRG samples and blood serum. 
Blood serum was diluted 1:7 to avoid matrix interference, while DRGs were lysed in RIPA 
buffer and diluted 1:6. 100 µl of serum (corresponding to 0.2 mg of proteins) and 100 µl of 
lysate (corresponding to 80 mg of proteins) were analysed with the Multi-Neurotrophin Rapid 
Screening ELISA kit (Biosensis), according to manufacturer’s instructions. The absorbance at 
450 nm of the samples, obtained using GLoMax plate reader (Promega), was interpolated 
against the standard curve to calculate the neurotrophin concentration, and referred to mg of 
proteins. 
 
Synthesis of carbon nanospheres of average size 350nm 
5 g of D(+) glucose was dissolved in 50 mL of deionised water to form a clear solution. The 
solution was placed in a 65 mL teflon lined sealed stainless steel autoclave and maintained at 
180 oC for 12 hr. The products were centrifuged at 10000 rpm for 10 min and were washed 
with water and ethanol thrice each before being dried in the oven at 60 oC for 4 hr. The final 
product is a brownish powder which had spheres with an average size of 350 nm. 
 
Synthesis of TTK21 
To the Dichloromethane (DCM)solution of 2-Propoxy Benzoic Acid (3.3mmol) one equivalent 
of thionyl chloride (3.66 mmol) and 4-5 drops of N, N-Dimethylformamide(DMF)  were added 
and the solution was refluxed for 4hr. Thionyl chloride was removed by evaporating the solvent 
3-4 times and to that DCM was added (Solution A). To the DCM solution of 4-Chloro-3-
(trifluoromethyl) amine (3.1 mmol) a few drops of triethylamine was added at 0 ⁰C and was 
stirred for 30 min (Solution B). The solution B was added drop-wise to the solution A at 0 ⁰C 
and after sometime the solution was heated to reflux for 4 hr. Then the solution was evaporated 
to dryness and was purified by column chromatography. White crystalline solid was obtained.  
 
Conjugation of TTK21 to CSP 
CSP suspension in DCM was reacted with one equivalent of SOCl2 and few drops of DMF. 
The reaction mixture was refluxed at room temperature for 4hr. Thionyl chloride was removed 
by evaporating the solvent 3-4 times and to that DCM was added to make the suspension. To 
that suspension one equivalent TTK21 and few drops of triethylamine were added. The reaction 
was refluxed for 4 hr. The suspension was filtered and the precipitate was washed with DCM. 
The conjugated CSP-TTK21 was dried. The conjugation of TTK21 to the nanosphere was 
analysed by Energy Dispersive X-ray Spectroscopy EDX. The spectrum of CSP-TTK21 shows 
that wt % of Fluorineis 0.31 which belongs to TTK21 indicating the covalent conjugation of 
TTK21 to CSP. 
 
CSP-TTK21 administration 
Animals were randomised to treatment with the CBP/p300 activator bound to carbon 
nanospheres (CSP-TTK21) or a control of just carbon nanospheres (CSP) (mice – 20 mg/kg, 
rats – 10 mg/kg injected IP once a week). Mice received the first IP injection 4 hours after SCI 
and tats received the first IP injection 6 hours after SCI to simulate a clinically-feasible delay-
to-treatment and then once a week thereafter. The optimal dose and time-course for retention 
of the small molecule-bound nanospheres in the CNS had been previously determined (33). 
CSP-TTK21 activates CBP 4 fold more potently than p300. No adverse effects were observed 
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following IP administration of CSP-TTK21 and after histological analysis no obvious cellular 
toxicity was observed. 
 
AAV-DREADD experiments 
Non-Cre dependent DREADD AAV vectors (AAV5-CaMKIIa-EGFP, AAV-CaMKIIa-HA-
hM3D(Gq)-IRES-mCitrine, AAV-CaMKIIa-HA-hM4D(Gi)-IRES-mCitrine) were purchased 
from UNC vector core. Viral titres were matched to 1x1013 GC/ml. 3 µl of Non-cre dependent 
AAV vector was injected in to the sciatic nerve to transduce DRG neurons. 4 weeks later the 
mice were placed in EE or SH for 10 days and given 0.05 mg/ml CNO with 5 mM sucrose in 
their drinking water each day, mice received approximately 5mg/kg CNO per day.  
To determine whether any observed increase in conduction across the lesion site was 
contingent on regenerating axons. Cre-dependent AAV-DREADD vector (AAV-hSyn-DIO-
hM4D(Gi)-mCherry) was purchased from UNC vector core. Titre was 1x1013 GC/ml. 3 weeks 
after a T9 dorsal hemisection 0.5 µl of cre-dependent AAV5-DREADD-Gi vector was injected 
in to the spinal cord at T7. 3 weeks later during terminal electrophysiological experiments mice 
received an I.P. injection of CNO (1.2 mg/kg body weight). 
 
Statistical analysis 
Results are expressed as mean values ± SEM and n values represent the number of animals in 
the experiment. Statistical analysis was carried out using Graphpad Prism 7 (GraphPad, prism 
software). The Kolmogorov– Smirnov and Levene’s tests were used to test for normality and 
the equality of variances. A two-tailed unpaired Student’s t-test, one-way ANOVA for 
evaluation of experiments with more than two groups, and one- or two-way repeated-
measures ANOVA for functional assessments, were used. Tukey’s, Sidak’s or Fisher’s LSD 
post-hoc tests were applied when appropriate. Behavioral assays were replicated two or three 
times, depending on the experiment, and averaged per animal. Statistics were then 
performed over the mean of animals. A threshold level of significance α was set at P<0.05. 










Fig. S1 Exposure to EE enhances neurite outgrowth on inhibitory myelin substrate to a 
similar extent as a conditioning SNA injury. (A) Representative images of DRG neurons 
cultured on an inhibitory myelin substrate for 12 hours and stained for Beta-III-tubulin. Scale 
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bar, 100 µm. (B) Quantification of neurite outgrowth per neuron demonstrated that EE 
significantly increased neurite outgrowth compared to SH to a similar level as SNA (mean ± 
SEM, One-way ANOVA, Tukey’s post-hoc *** P<0.001, n = 4/group). 
 
 
Fig. S2 Inhibiting transcription with actinomycin-D blocks the EE-mediated increase in 
DRG neurite outgrowth. (A) Representative images of DRG neurons cultured for 12hr with 
vehicle, 0.01 µg/µl or 1 µg/µl actinomycin-D. (B) Quantification of neurite outgrowth per 
neuron demonstrated that the EE-mediated increase in neurite outgrowth was dependent on 




Fig. S3. Exposure to EE enhances axon elongation rather than branching. (A) 
Representative images of cultured DRGs from mice that had been in SH or EE for 10 days, 
DRGs were stained for Beta-III-tubulin. Scale bar, 100 µm. (B) Quantification of the mean 
number of branches per 100 µm showed a significant reduction in neurite branching after 





Fig. S4. The full EE increases DRG neurite outgrowth compared to the running wheel 
alone.  (A) Example images of cultured DRGs stained for Beta-III-tubulin after exposure to 
EE, SH, SH with a wheel or EE with an immobilised wheel. Scale bar, 100 µm. (B) Mean 
neurite outgrowth per neuron was quantified and we observed a significant difference between 
all the groups except the SH + wheel and EE – wheel groups (mean ± SEM, One-way ANOVA, 





Fig. S5. Exposure to EE enhances muscle re-innervation by proprioceptive DRG neurons. 
(A) Representative images of sciatic DRGs from mice that had been in SH or EE for 10 days 
prior to a sciatic nerve crush injury, followed by injections of CTB into hind limb muscles 14 
days later to assess muscle re-innervation. (B) Quantification of the number of CTB positive 
DRG neurons suggests EE significantly enhances muscle re-innervation compared to SH (mean 
± SEM, unpaired Student’s t test, ** P<0.01, n = 4/group). (C) Quantification of the percentage 
of CTB positive neurons that co-localized with parvalbumin demonstrates a higher level of co-




Fig. S6. EE promotes axon regeneration and the formation of putative synapses. 
Representative image from a EE smouse showing co-localisation of regenerating CTB (red) 
positive axons rostral to the spinal cord injury site (marked by the dashed line and asteriks) 
with the pre-synaptic marker vGlut1 (green) to identify presynaptic excitatory boutons and 
prospective nascent synapses (marked by arrows). Scale bar, 100 µm. Higher-magnification 
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images of insets in show co-localisation of CTB positive axons (red) and vGlut1 (green). Scale 




Fig. S7. Neurotrophin and cytokine levels in the DRG and blood serum are not affected 
by EE. (A) Quantification of neurotrophin protein levels in whole DRG lysate shows no 
significant differences between SH and EE (mean ± SEM, Two-way ANOVA, Sidak’s post-
hoc, n = 3/group). (B) Quantification of cytokine levels in whole DRG lysate shows no 
differences between SH and EE (mean ± SEM, Two-way ANOVA, Sidak’s post-hoc, n = 
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4/group). (C) Quantification of cytokine level in blood serum shows no differences between 





Fig. S8. RNAseq and proteomic datasets demonstrate that EE strongly modulates 
pathways involved in neuronal activity, calcium signaling, gene expression and 
cytoskeletal changes. (A) Area proportional Venn diagram of differentially expressed (DE) 
genes (P<0.05) in Whole DRG vs LDN. (B) Histogram of the numbers of DE genes (P<0.05) 
in the Whole DRG vs LDN and (C) axoplasmic proteins (P <0.05, or difference > 4 peptides). 
(D) GO clustering of the DE genes in LDN dataset run with ClueGO in Cytoscape: (Bonferroni 
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P<0.05). Each edge represents interrelation between terms, defined by the K score. (E) 
Cytoscape visualization of the protein-protein interactions calculated by String. Each node 
represents a DE gene (RNAseq) or protein (proteomic). Red borders highlight nodes found DE 
at both gene and protein level. Edges represent protein-protein interactions, where their width 
reflects the Edge Betweenness. Circle shape: Up-regulated. Square shape: down-regulated. The 





Fig. S9. Efficient transduction and DREADD expression in parvalbumin positive DRGs. 
(A) Image of a DRG section transduced with AAV5-GFP (green) and stained with parvalbumin 
(red). Scale bar, 50 µm. (B) Quantification of transduction efficiencies of AAV5-GFP in 
parvalbumin positive DRGs (mean ± SEM, unpaired Student’s t test n/s, n = 6/group). (C) 
Image of a DRG section transduced with AAV5-hM4Di-mCitrine (green) and stained with 
parvalbumin (red). Scale bar, 50 µm. (D) Quantification of transduction efficiencies of AAV5-
hM4Di-mCitrine in parvalbumin positive DRGs (mean ± SEM, unpaired Student’s t test n/s, n 
= 6/group). (E) Image of a DRG section transduced with AAV5-hM3Dq-mCitrine (green) and 
stained with parvalbumin (red). Scale bar, 50 µm. (F) Quantification of transduction 
efficiencies of AAV5-hM3Dq-mCitrine in parvalbumin positive DRGs (mean ± SEM, 






Fig. S10. The EE-mediated increase in DRG neurite outgrowth is mediated by neuronal 
activity. (A) Example images of cultured DRGs which had been transduced with AAV-GFP, 
AAV-DREADD-Gi or AAV-DREADD-Gq and then exposed to SH or EE for 10 days. AAV 
vectors expressed GFP or mCitrine (green) to identify transduced DRGs which were also 
stained for Beta-III-tubulin (red). Scale bar, 100 µm. (B) Quantification of the neurite 
outgrowth per neuron showed that increasing neuronal activity with DREADD-Gq in DRGs 
from SH mice increased outgrowth to a similar level as EE. Silencing DRGs from EE mice 
with DREADD-Di significantly reduced neurite outgrowth compared to EE (mean ± SEM, 






Fig. S11. H3K27ac is increased in parvalbumin positive DRGs after exposure to EE but 
the levels of H3K4me2, H3K9ac and H3K4me3 do not change compared to SH. (A) 
Representative images of DRGs from mice housed in SH or EE, which were stained for 
H3K27ac (green), parvalbumin (red). Scale bar, 50 µm. (B) Quantification of the fluorescence 
intensity of H3K27ac in the nuclei of parvalbumin positive DRGs showed a significant increase 
after EE compared to SH (mean ± SEM, unpaired Student’s t test ** P<0.01, n = 4/group). (C, 
E and G) Representative images of DRG from mice that had been exposed to SH or EE for 10 
days and then stained for parvalbumin (red) and H3K4me2 (C) H3K9ac (E) and H3K4me3 
(G)  in green. Scale bar, 50 µm. (D, F and H) Quantification of the fluorescence intensity of 
H3K4me2, H3K9ac and H3K4me3 in the nuclei of parvalbumin positive DRGs showed no 
significant difference between the SH and EE groups (mean ± SEM, unpaired Student’s t test, 





Fig. S12. Levels of H4K8ac but not acCBP or pCREB remain elevated in parvalbumin 
positive DRGs for 5 weeks after exposure to EE. (A) Images of DRGs stained for 
parvalbumin (red) and H4K8ac (green) and DAPI (blue) from mice exposed to SH or EE for 
10 days and then placed in SH for 5 weeks. Scale bar, 50 µm. (B) Quantification of the 
fluorescence intensity of H4K8ac demonstrated a significant increase in parvalbumin positive 
DRGs from mice previously exposed to EE compared to SH (mean ± SEM, unpaired Student’s 
t test ** P<0.01, n = 6/group). (C) Images of DRGs stained for parvalbumin (red) and acCBP 
(green) from mice exposed to SH or EE for 10 days and then placed in SH for 5 weeks. Scale 
bar, 50 µm. (D) Quantification demonstrated no significant increase in acCBP levels in 
parvalbumin positive DRGs from mice previously exposed to EE (mean ± SEM, unpaired 
Student’s t test, n/s, n = 6/group). (E) DRGs stained for parvalbumin (red) and pCREB (green) 
from mice exposed to SH or EE for 10 days and then placed in SH for 5 weeks. Scale bar, 50 
µm. (F) Quantification showed no significant increase in pCREB levels in parvalbumin 
positive DRGs from mice previously exposed to EE (mean ± SEM, unpaired Student’s t test, 





Fig. S13. Increasing neuronal activity augments the level of H4K8ac and acCBP in DRG 
neurons. (A) Images of DRGs stained for parvalbumin (red) and H4K8ac (green) from SH 
mice expressing hM3Dq or EE mice expressing hM4Di. Scale bar, 50 µm. (B) Quantification 
of the fluorescence intensity of H4K8ac demonstrated a significant increase in parvalbumin 
positive DRGs from SH mice that express DREADD-Gq compared to DRGs from EE mice 
that express DREADD-Gi (mean ± SEM, unpaired Student’s t test ** P<0.01, n = 6/group). 
(C) Images of DRGs stained for total-CBP (red) and acCBP (green) from SH mice expressing 
DREADD-Gq or EE mice expressing DREADD-Gi. Scale bar, 50 µm. (D) Quantification of 
the fluorescence intensity revealed that DRGs from SH mice that express DREADD-Gq had 
significantly increased the levels of acCBP relative to total-CBP compared to DRGs from EE 






Fig. S14. The CaMKIIa promoter is active in DRG neurons and drives strong expression 
of tdTomato after tamoxifen treatment. Cre-dependent LoxP-STOP-LoxP tdTomato 
reporter mice were crossed with WT mice or CamKIIa-CreERT2 mice. Tamoxifen treated 
WT/lox-tdTomato mice show no tdTomato expression in the DRGs. Tamoxifen treated 
CamKIIa-CreERT2/lox-tdTomato mice show strong expression of tdTomato in DRG neurons. 




Fig. S15. CSP-TTK21 treatment significantly enhances the time to remove adhesive tape 
placed on the hindpaw. Quantification of the time it took to remove adhesive pad placed on 
the hindpaws (mean ± SEM, Two-way repeated measures ANOVA, Fisher’s LSD post-hoc 





Fig. S16. CSP-TTK21 treatment promotes sprouting of afferent fibres below the level of 
injury. (A) Representative images of one half of the L1-3 spinal cord immunolabelled for 
vGlut1 from CSP and CSP-TTK21 treated mice, combined to a schematic showing the spinal 
laminae. Scale bar, 250 µm. (B) Quantification of vGlut1 pixel intensity in lamina V was 
significantly increased after CSP-TTK21 treatment compared to CSP treatment (mean ± SEM, 




Fig. S17. CSP-TTK21 treatment enhances H4K8ac in the DRG. (A) Representative images 
of DRGs from mice treated with CSP or CSP-TTK21 for 5 weeks, which were stained for 
H4K8ac (green), parvalbumin (red) and DAPI (blue). Scale bar, 50 µm. (B) Quantification of 
the fluorescence intensity of H4K8ac in the nuclei of parvalbumin positive DRGs showed a 
significant increase after CSP-TTK21 treatment compared to CSP (mean ± SEM, unpaired 
Student’s t test ** P<0.01, n = 4/group). (C) Immunoblotting analysis for H4K8ac from protein 
extracts from whole sciatic DRGs after treatment with CSP or CSP-TTK21 for 5 weeks. Shown 
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is a significant increase in the expression of H4K8ac after treatment with CSP-TTK21 
compared to CSP (mean ± SEM, unpaired Student’s t test, ** P<0.01, n = 3/group). H4 was 




Fig. S18. CSP-TTK21 treatment does not affect the glial scar after a thoracic dorsal spinal 
cord hemisection in mice. (A) Example images of the T12 spinal lesion site immunolabelled 
for GFAP to identify reactive astrocytes and the glial scar after CSP or CSP-TTK21 treatment. 
Scale bar, 200 µm. (B) Quantification of the area of GFAP positive scar showed no difference 
between CSP and CSP-TTK21 treated mice (mean ± SEM, unpaired Student’s t test, n = 
8/group). (C) Quantification of GFAP pixel intensity around the lesion site showed no 
difference between CSP and CSP-TTK21 treated mice (mean ± SEM, unpaired Student’s t test, 




Fig. S19. CSP-TTK21 significantly reduced the number of slips during locomotion along 
a horizontal ladder. Quantification of percentage of slips (mean ± SEM, Two-way repeated 





Fig. S20. CSP-TTK21 treatment enhances levels of H4K8ac in the raphe nucleus and 
reticular formation. (A) Schematic and representative image of the Raphe nucleus (Ra) 
stained for 5HT. (B) Treatment with CSP-TTK21 significantly enhanced H4K8ac (green) in 
5HT positive neurons (red) in the Raphe nucleus. (C) Schematic and representative image of 
the ventral gigantocellular reticular nuclei (vGi) transduced with AAV8-CAG-DIO-
tdTomato-COMET. (D) Treatment with CSP-TTK21 significantly enhanced levels of H4K8ac 




Fig. S21. CSP-TTK21 treatment does not affect the glial scar after a thoracic contusion 
spinal cord injury in rats. (A) Example images of the thoracic contusion site immunolabelled 
for GFAP to identify reactive astrocytes and the glial scar after CSP or CSP-TTK21 treatment. 
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Scale bar, 500 µm. (B) Quantification of GFAP pixel intensity around the lesion site showed 
no difference between CSP and CSP-TTK21 treated mice (mean ± SEM, unpaired Student’s t 
test, n = 12/group). (C) Quantification of the GFAP positive scar area showed no difference 




Table S1. Table compiling the 78 parameters used for quantifying gait features. 
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Video S1. EE mediated calcium mobilization in proprioceptive DRG neurons. Time-lapse 
video of intracellular calcium release from whole-mount PV-GCaMP DRGs. Mice were 
exposed to EE for 10 days before dissection and calcium imaging. A baseline recording was 
taken before the addition of 50 mM, 100 mM and 150 mM KCL. Videos are 20 fps. 
 
Video S2. SH mediated calcium mobilization in proprioceptive DRG neurons. Time-lapse 
video of intracellular calcium release from whole-mount PV-GCaMP DRGs. Mice were 
exposed to SH for 10 days before dissection and calcium imaging. A baseline recording was 
taken before the addition of 50 mM, 100 mM and 150 mM KCL. Videos are 20 fps. 
 
Video S3. Treatment with CSP-TTK21 enhances hindlimb function and over-ground 
locomotion. Example movies showing kinematic recordings of rats 8 weeks after a contusion 
SCI and treatment with CSP or CSP-TTK21. 
 
 
 
 
 
 
